国际标准期刊号: 2161-1165

Epidemiology: Open Access

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 安全点亮
  • 访问全球在线农业研究 (AGORA)
  • 国际农业与生物科学中心 (CABI)
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • CABI 全文
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Telomere Length in Children with Acquired Severe Aplastic Anemia

Katarzyna Pawelec, Marek Janiak, Paweł Włodarski and Michał Matysiak

Objective: This study aimed to assess telomere length in children with severe aplastic anemia and to correlate this parameter with the response to immunosuppressive therapy

Method: The study group consisted of 18 children aged with severe aplastic anemia (SAA) treated with rabbit antithymocyte globulin and cyclosporine from one of hematology center. Telomere length was analyzed in all patients and in 20 parents. Control group was composed of 12 healthy children and 12 healthy adults. Telomere length in peripheral blood was assessed using polymerase chain reaction (PCR).

Result: There was statistical significance between telomere length in patients with SAA and healthy children (p=0.03852) as well as in parents of SAA children and adults from control group (p=0.01086). There was no difference concerning response to IST in relation to telomere length (p=0.7859).

Conclusion: Our studies confirmed that pediatric patients with SAA and their parents have shorter telomeres compared to healthy population. The assessment of telomere length in diseases of short telomeres, including aplastic anemia, should be a diagnostic standard. Future studies are necessary to confirm the role of telomere length as an independent prognostic risk factor and a good predictor of prognosis in SAA.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。